Danaher(US:DHR) 仪器信息网·2026-01-13 07:40Core Viewpoint - The appointment of Yu Jing as the new president of Danaher’s China Diagnostics platform is expected to drive a new wave of transformation in the company, leveraging her extensive experience in digital transformation and product innovation from her previous roles at Medtronic and GE Healthcare [1]. Group 1 - Yu Jing previously served as the Vice President and General Manager of Medtronic's China Orthopedic and Neurosurgery business, where she led the digital transformation of the orthopedic and neurosurgery sectors [1]. - During her tenure at Medtronic from 2019 to 2025, she developed the AIBLE digital orthopedic and neurosurgery integrated solutions and established an innovation incubation center in Changzhou [1]. - Yu Jing's leadership is anticipated to enhance Danaher’s capabilities in digital transformation and product innovation within the diagnostics sector in China [1]. Group 2 - Chen Xiaosui made significant and lasting contributions to Beckman Coulter Diagnostics China and Danaher’s China Diagnostics platform, strengthening operational capabilities in the region [2]. - Under Chen's leadership, the team fostered collaboration among diagnostic business units, helping to unify goals and increase impact in China's dynamic healthcare market [2]. - Chen led initiatives for localization and open innovation, aligning Danaher’s product offerings more closely with market demands while enhancing quality, compliance, and customer experience standards [2].